|
|
 |
|
Viewing report
|
|
|
|
Allergan Inc.: PharmaVitae Profile
Datamonitor, Oct 2009, Pages: 90
This analysis examines the historical and forecast performance for Allergan in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Key reasons to purchase this title
- Benchmark Allergan's performance against key rivals in the prescription pharmaceutical sector
- Assess how the key Botox franchise stands up to the global recession and the arrival of further competitors
- Analyze the impact of Allergan's acquisition of Esprit Pharma in 2007, namely its movement into the urology therapy market
Customers who bought this item also bought
Allergan Inc.: PharmaVitae Model
Allergan: PharmaVitae Profile
Allergan: Performance, Products, Pipeline and Potential
Allergan, Inc. - SWOT Analysis
Company Analysis - Allergan, Inc.
Pharmavitae 2005: Allergan Global Analysis
PharmaVitae 2004: Allergan Global Analysis
Allergan, Inc. Product Pipeline Analysis
Pharmavitae 2005: Allergan Global & Us Analysis
PharmaVitae 2004: Allergan Global & US Analysis
Analysis of the Allergan Inc.
Allergan, Inc.
|
|
|
|
